Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury

[21] Burroughs AK(2013)Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels Int J Cardiol. 168 3846-e81

[22] Rzouq FS(2019)Statin safety and associated adverse events: a scientific statement from the American Heart Association Arterioscler Thromb Vasc Biol. 39 e38-269

[23] Volk ML(1994)Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study Eur Heart J. 15 255-22

[24] Hatoum HH(2002)MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised placebo-controlled trial Lancet. 360 7-774

[25] Lewis JH(2009)Alcohol-related cirrhosis-early abstinence is a key factor in prognosis, even in the most severe cases Addiction. 104 768-undefined

[26] Mortensen ME(undefined)undefined undefined undefined undefined-undefined

[27] Zweig S(undefined)undefined undefined undefined undefined-undefined

[28] Cohen DE(undefined)undefined undefined undefined undefined-undefined

[29] Anania FA(undefined)undefined undefined undefined undefined-undefined

[30] Chalasani N(undefined)undefined undefined undefined undefined-undefined

[21] Burroughs AK(2013)Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels Int J Cardiol. 168 3846-e81

[22] Rzouq FS(2019)Statin safety and associated adverse events: a scientific statement from the American Heart Association Arterioscler Thromb Vasc Biol. 39 e38-269

[23] Volk ML(1994)Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study Eur Heart J. 15 255-22

[24] Hatoum HH(2002)MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised placebo-controlled trial Lancet. 360 7-774

[25] Lewis JH(2009)Alcohol-related cirrhosis-early abstinence is a key factor in prognosis, even in the most severe cases Addiction. 104 768-undefined

[26] Mortensen ME(undefined)undefined undefined undefined undefined-undefined

[27] Zweig S(undefined)undefined undefined undefined undefined-undefined

[28] Cohen DE(undefined)undefined undefined undefined undefined-undefined

[29] Anania FA(undefined)undefined undefined undefined undefined-undefined

[30] Chalasani N(undefined)undefined undefined undefined undefined-undefined